METHODS FOR TREATMENT OF RELAPSED/REFRACTORY FOLLICULAR LYMPHOMA WITH MOSUNETUZUMAB AND LENALIDOMIDE
Abstract:
The present invention relates to the treatment of subjects having relapsed and/or refractory (R/R) follicular lymphoma (FL). More specifically, the invention pertains to the treatment of subjects having R/R FL by administering a combination of mosunetuzumab and lenalidomide.
Information query
Patent Agency Ranking
0/0